Nocturnal Hypoxemia Severity Linked to Renal RAS Activity

Share this content:
Nocturnal Hypoxemia Severity Linked to Renal RAS Activity
Nocturnal Hypoxemia Severity Linked to Renal RAS Activity

WEDNESDAY, Oct. 21, 2015 (HealthDay News) -- In obstructive sleep apnea (OSA), the severity of nocturnal hypoxemia is associated with the extent to which renal renin-angiotensin system (RAS) activity is increased, according to a study published in the Oct. 1 issue of the American Journal of Respiratory and Critical Care Medicine.

Ann A. Zalucky, from the University of Calgary in Canada, and colleagues examined the correlation between the severity of nocturnal hypoxemia and RAS activity. In 31 subjects with OSA and 13 obese controls, the authors measured effective renal plasma flow (ERPF) response to angiotensin II (AngII) challenge, a marker of renal RAS activity.

The researchers found that OSA subjects demonstrated decreased renovascular sensitivity compared with controls (P = 0.004) in response to 60 minutes of AngII challenge. In patients with severe hypoxemia, the fall in ERPF in response to AngII was less than in those with moderate hypoxemia (P = 0.001) and less than in obese control subjects after 30 and 60 minutes of AngII challenge (both P < 0.001). There was no association for severity of hypoxemia with the blood pressure or the systemic circulating RAS component response to AngII.

"The severity of nocturnal hypoxemia influences the magnitude of renal, but not the systemic, RAS activation independently of obesity in patients with OSA," the authors write.

Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA Permits Marketing of Brain Stimulation Device for OCD

FDA Permits Marketing of Brain Stimulation Device for ...

FDA previously approved transcranial magnetic stimulation for major depression, certain migraines

Comments Open on End of NIH Review for Gene Therapy Studies

Comments Open on End of NIH Review for ...

NIH oversight panel no longer plans to review all applications for gene therapy experiments

U.S. Measles Outbreak Hits 107 Cases in 21 States, D.C.

U.S. Measles Outbreak Hits 107 Cases in 21 ...

Outbreak on track to exceed last year's; most of the people who got measles weren't vaccinated

is free, fast, and customized just for you!




Already a member?

Sign In Now »